Study limitation: Full text is under PMC embargo until August 20, 2027; summary is based solely on the published abstract and results section provided | ReachRx
TERT
Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma
Study limitation reported by the research below: “Full text is under PMC embargo until August 20, 2027; summary is based solely on the published abstract and results section provided.”
